nhc20221103_8k.htm
false 0001047335 0001047335 2022-11-03 2022-11-03
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 4, 2022 (November 3, 2022)
 
 
NATIONAL HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
001-13489
52-2057472
(State or other jurisdiction of
incorporation)
 (Commission File Number) (I.R.S. Employer Identification No.)
100 E. Vine Street
Murfreesboro, Tennessee
  
37130
(Address of Principal Executive
Offices)
   (Zip Code)
 
Registrant’s telephone number, including area code: (615) 890-2020
 
Not Applicable
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Exchange Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $.01 par value
NHC
NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
ITEM 2.02.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION
 
National HealthCare Corporation (“NHC”) issued a press release on November 3, 2022, announcing its September 30, 2022 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.
 
 
ITEM 8.01.
OTHER EVENTS.
 
NHC issued a press release on November 4, 2022, announcing its quarterly common dividend. The entire press release is attached as Exhibit 99.2 and is incorporated by reference herein.
 
 
ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS.
 
(d)         Exhibits.
 
Exhibit No.
Description of Exhibit
99.1
Copy of press release issued on November 3, 2022, by National HealthCare Corporation announcing September 30, 2022 earnings.
   
99.2 Copy of press release issued on November 4, 2022 by National HealthCare Corporation announcing quarterly common dividend.
   
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:         November 4, 2022
 
  NATIONAL HEALTHCARE CORPORATION
     
  By: /s/ Brian F. Kidd
  Name: Brian F. Kidd
  Title:
Senior VP/Controller
Principal Accounting Officer